Back

GLP-1 receptor agonists for smoking cessation after acute coronary syndrome: from biological plausibility to clinical impact

29 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Smoking and the heart Tobacco ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Antonio Meseguer Hernandez

General University Hospital Santa Lucia, Cartagena (Spain)

7 More presentations in this session

Presentation thumbnail
Cumulative smoking exposure and prevalence of silent atherosclerosis in the REACT study
Miss A. Abdulhussein Ahmad (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Electronic smoking device use in Brazil: nationally representative comparative analysis of adolescents and adults
Mr L. Castro Carvalho (BR)
Abstract Slides
Presentation thumbnail
Persistence of smoking following acute coronary syndrome: insights from a two-year single-center study
Doctor R. Esculudes Dos Santos Ferrao Gomes (Lisboa, PT)
Abstract Slides
Presentation thumbnail
Breaking the habit: comparative effectiveness of smoking cessation therapies in a cardiovascular hospital based clinical setting
Doctor E. Georgousi (Athens, GR)
Abstract Slides
Presentation thumbnail
Twenty-year trends in nicotine exposure and educational disparities in Brazil
Doctor R. Goes (Asa Sul Brasilia, BR)
Abstract Slides

Access the full session

Session thumbnail
Smoking and the heart

The Event

Event poster

ESC Congress 2026

29 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Identification of factors associated with smoking cessation in patients with coronary artery diseases. Findings from a large nationwide cohort of smoking cessation services
27 August 2022
thumbnail
Webinar
GLP-1 RAs and HFpEF : what do we know from large RCTs about GLP-1 RAs and their effects on HFpEF?
24 November 2025
thumbnail
Congress Presentation
Adherence and discontinuation of sglt2-inhibitors and glp1-r agonists in patients with type 2 diabetes with and without cardiovascular disease
27 August 2022
thumbnail
Congress Presentation
Promoting active recovery: impact of a cardiac rehabilitation program on lifestyle and risk factor control after acute coronary syndrome
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources